214610 — MiCo BioMed Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Market Cap
KR₩25bn
Enterprise Value
KR₩33bn
Revenue
KR₩5bn

Annual balance sheet for MiCo BioMed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24,133	36,868	14,277	22,638	13,773
Net Total Accounts Receivable
Net Total Receivables	11,435	11,790	2,346	10,191	2,658
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	57,311	69,681	36,531	47,387	26,709
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11,671	16,058	10,401	5,606	20,239
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	70,960	88,677	57,512	61,318	54,467
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8,875	11,723	27,430	17,535	13,948
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	14,998	36,419	39,819	24,337	28,581
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	55,961	52,259	17,693	36,981	25,885
Total Liabilities & Shareholders' Equity	70,960	88,677	57,512	61,318	54,467
Total Common Shares Outstanding